Utah Medical Products, Inc. (NASDAQ:UTMD) CEO Kevin L. Cornwell sold 3,967 shares of Utah Medical Products stock in a transaction on Tuesday, June 12th. The shares were sold at an average price of $105.23, for a total transaction of $417,447.41. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of NASDAQ:UTMD traded up $0.60 during midday trading on Thursday, hitting $104.70. The stock had a trading volume of 363 shares, compared to its average volume of 14,671. The company has a market cap of $391.71 million, a price-to-earnings ratio of 25.93 and a beta of 0.60. Utah Medical Products, Inc. has a 1 year low of $68.10 and a 1 year high of $109.65.
Utah Medical Products (NASDAQ:UTMD) last issued its earnings results on Thursday, April 26th. The medical instruments supplier reported $1.09 earnings per share for the quarter. The business had revenue of $10.89 million for the quarter. Utah Medical Products had a net margin of 21.56% and a return on equity of 18.94%.
A number of research analysts have commented on the stock. BidaskClub lowered shares of Utah Medical Products from a “buy” rating to a “hold” rating in a research note on Friday, June 8th. ValuEngine upgraded shares of Utah Medical Products from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd.
Large investors have recently modified their holdings of the company. MetLife Investment Advisors LLC purchased a new stake in shares of Utah Medical Products in the fourth quarter valued at about $163,000. Barclays PLC boosted its holdings in shares of Utah Medical Products by 93.3% in the first quarter. Barclays PLC now owns 2,208 shares of the medical instruments supplier’s stock valued at $218,000 after acquiring an additional 1,066 shares in the last quarter. SG Americas Securities LLC purchased a new stake in shares of Utah Medical Products in the fourth quarter valued at about $189,000. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Utah Medical Products in the fourth quarter valued at about $289,000. Finally, Prudential Financial Inc. boosted its holdings in shares of Utah Medical Products by 22.4% in the first quarter. Prudential Financial Inc. now owns 3,811 shares of the medical instruments supplier’s stock valued at $377,000 after acquiring an additional 697 shares in the last quarter. 69.26% of the stock is currently owned by institutional investors and hedge funds.
Utah Medical Products Company Profile
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.